Ultrasound-guided radiofrequency is generally a safe treatment for liver masses and carries an acceptable level of risk, but patients with large tumors and baseline liver function impairment have a higher risk of complications, according to researchers in Taiwan.
Ultrasound-guided radiofrequency is generally a safe treatment for liver masses and carries an acceptable level of risk, but patients with large tumors and baseline liver function impairment have a higher risk of complications, according to researchers in Taiwan.
Dr. Tsung-Ming Chen and colleagues in the hepatogastroenterology division of the internal medicine department at Tungs' Taichung MetroHarbor Hospital in Taiwan published their paper online in August with the Journal of Gastroenterology and Hepatology. They studied results from all patients at a single center treated by one physician, 104 in all, with a total of 183 tumors.
The analysis included 172 ultrasound-guided percutaneous radiofrequency ablation sessions between May 2003 and March 2006 on 86 hepatocellular carcinomas and 18 hepatic metastatic tumors. They found only nine major complications as defined by the standardized Society of Interventional Radiology grading system, resulting in an incidence of 5.2% chance per session.
These nine complications included two cases of transient liver function impairment, one case of liver abscess, one case of septicemia, two cases of tumor seeding along the ablated track, one case of colon perforation, one case of acalculous cholecystitis and one case of hemocholecyst. In analyzing these cases, they found tumor size and baseline liver function reserve were the only risk factors contributing to the complication of transient liver function impairment.
The researchers concluded that patients with a large tumor size and baseline liver function impairment should be watched more carefully in follow-up.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.